Our COO Graeme Fielder is looking forward to joining the panel at One Nucleus BioWednesday London this evening. He’ll be discussing Deal-making for Cell and Gene Therapy Companies - what makes these different to deals for small molecules or other types of therapies and what are the top priorities for those looking to invest in or acquire cell or gene therapy businesses. He’s joined by a great line up of speakers Claire Smith Bristows, Jodie Albutt, Quell Therapeutics, Nuno Alves, PhD, Astellas Pharma and Pedro Correa de Sampaio, Neobe Therapeutics. Find out more https://lnkd.in/d6YY7__Y
Good luck, Graeme!
It's fantastic to see Graeme Fielder from your team participating in such an important discussion on deal-making for cell and gene therapy companies. The lineup of speakers seems impressive, and I'm sure the insights shared will be valuable for investors and professionals in this field. Wishing you all a successful and enlightening event!